Re:How India's Patent Office Destroyed Gilead's Global Game ...
by refurb on Friday January 16, 2015 @10:53AM
(#8899622)
You don't have to have head-to-head data to claim your drug is superior to existing therapies. Yes, head-to-head data is the best way to show it, but if you have two separate trials, each comparing to a placebo, you can draw conclusions about relative efficacy. It's not perfect, but in the case of Gilead, their drug blows away anything else currently on the market.
[ Parent
| on HN ]
There are no comments on this comment yet.